Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, (i) development and contract manufacturing of generic dermatological solutions; and (ii) developing and formulating solutions to specific The Company operates in only one segment which is dealing in pharma products dermatological problem.
2017
84
LTM Revenue n/a
LTM EBITDA n/a
$15.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amwill Healthcare has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Amwill Healthcare achieved revenue of $5.1M and an EBITDA of $1.9M.
Amwill Healthcare expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Amwill Healthcare valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $3.5M | $5.1M | XXX | XXX | XXX |
Gross Profit | $2.2M | $2.5M | XXX | XXX | XXX |
Gross Margin | 62% | 48% | XXX | XXX | XXX |
EBITDA | $0.5M | $1.9M | XXX | XXX | XXX |
EBITDA Margin | 15% | 38% | XXX | XXX | XXX |
Net Profit | $0.3M | $0.4M | XXX | XXX | XXX |
Net Margin | 9% | 7% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Amwill Healthcare's stock price is INR 75 (or $1).
Amwill Healthcare has current market cap of INR 1.5B (or $17.4M), and EV of INR 1.4B (or $15.9M).
See Amwill Healthcare trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$15.9M | $17.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Amwill Healthcare has market cap of $17.4M and EV of $15.9M.
Amwill Healthcare's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Amwill Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Amwill Healthcare and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $15.9M | XXX | XXX | XXX |
EV/Revenue | 3.1x | XXX | XXX | XXX |
EV/EBITDA | 8.2x | XXX | XXX | XXX |
P/E | 11.9x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -34.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAmwill Healthcare's NTM/LTM revenue growth is n/a
Amwill Healthcare's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $21K for the same period.
Over next 12 months, Amwill Healthcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Amwill Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Amwill Healthcare and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 46% | XXX | XXX | XXX | XXX |
EBITDA Margin | 38% | XXX | XXX | XXX | XXX |
EBITDA Growth | 281% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $21K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 35% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amwill Healthcare acquired XXX companies to date.
Last acquisition by Amwill Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Amwill Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Amwill Healthcare founded? | Amwill Healthcare was founded in 2017. |
Where is Amwill Healthcare headquartered? | Amwill Healthcare is headquartered in India. |
How many employees does Amwill Healthcare have? | As of today, Amwill Healthcare has 84 employees. |
Is Amwill Healthcare publicy listed? | Yes, Amwill Healthcare is a public company listed on BOM. |
What is the stock symbol of Amwill Healthcare? | Amwill Healthcare trades under 544353 ticker. |
When did Amwill Healthcare go public? | Amwill Healthcare went public in 2025. |
Who are competitors of Amwill Healthcare? | Similar companies to Amwill Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Amwill Healthcare? | Amwill Healthcare's current market cap is $17.4M |
What is the current revenue growth of Amwill Healthcare? | Amwill Healthcare revenue growth between 2023 and 2024 was 46%. |
Is Amwill Healthcare profitable? | Yes, Amwill Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.